Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.

ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...

Philip Morris International Inc.'s stock touched an record high on Thursday after it issued a profit outlook that topped Wall Street analyst expectations on strength in its smokeless-tobacco products.

Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris ...

The U.S. Food and Drug Administration (FDA) recently approved the marketing of 20 Zyn nicotine pouches, marking the first time nicotine pouches have received such authorization. This decision came ...

But the nicotine limit doesn't apply to vaping products, nicotine pouches such as Zyn, hookahs ... under Trump's earlier administration by FDA Commissioner Scott Gottlieb. The FDA said the ...

On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.

Philip Morris International Inc. (PMI) (NYSE: PM) today announces its 2024 fourth-quarter and full-year results.1 "2024 was a remarkable year ...

Following an extensive scientific review, the U.S. Food and Drug Administration, FDA, authorized the marketing of 20 ZYN nicotine pouch products through the premarket tobacco product application ...